Hundreds of flawed coronavirus clinical trials amount to 'wasted' effort and energy, experts say
If you've followed coronavirus research developments since the pandemic began, you're probably aware there have been quite a few clinical trials and studies aimed at finding a treatment or prevention for COVID-19. In fact, Stat News reports there have been 1,200 designed since January, which is a remarkable number in such a short amount of time. The problem is a lot of them are fatally flawed, a new analysis conducted by Stat found.
Robert Califf, the head of clinical policy and strategy at Verily Life Sciences and Google Health who previously served as commissioner for the Food and Drug Administration, said the analysis shows many studies are too small to answer questions (39 percent are enrolling or plan to enroll fewer than 100 patients), lack real control groups, and emphasized a few potential treatments (one out of every six focused on the President Trump-favored malaria drugs, hydroxychloroquine and chloroquine) too frequently. "If the goal was to optimize the likelihood of figuring out the best treatment options, the system is off course," he told Stat.
Martin Landray, a professor of medicine at Oxford University and a member of one of the more successful studies known as RECOVERY, said "it's a huge amount of wasted effort and wasted energy." To correct that, Landray and other experts have called for more "coordination and collaboration" across the globe. Read more at Stat News.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Judge blocks Louisiana 10 Commandments law
Speed Read U.S. District Judge John deGravelles ruled that a law ordering schools to display the Ten Commandments in classrooms was unconstitutional
By Peter Weber, The Week US Published
-
ATF finalizes rule to close 'gun show loophole'
Speed Read Biden moves to expand background checks for gun buyers
By Peter Weber, The Week US Published
-
Hong Kong passes tough new security law
Speed Read It will allow the government to further suppress all forms of dissent
By Peter Weber, The Week US Published
-
France enshrines abortion rights in constitution
speed read It became the first country to make abortion a constitutional right
By Peter Weber, The Week US Published
-
Texas executes man despite contested evidence
Speed Read Texas rejected calls for a rehearing of Ivan Cantu's case amid recanted testimony and allegations of suppressed exculpatory evidence
By Peter Weber, The Week US Published
-
Supreme Court wary of state social media regulations
Speed Read A majority of justices appeared skeptical that Texas and Florida were lawfully protecting the free speech rights of users
By Peter Weber, The Week US Published
-
Greece legalizes same-sex marriage
Speed Read Greece becomes the first Orthodox Christian country to enshrine marriage equality in law
By Peter Weber, The Week US Published
-
Trump and his lawyer Alina Habba have a rough day in defamation court
Speed Read Trump's audible grousing as E. Jean Carroll testified earned him a warning he could be thrown out of court, and Habba showed she 'doesn't know what the hell she's doing'
By Peter Weber, The Week US Published